Första AP-fonden’s NovoCure NVCR Stock Holding History

Första AP-fonden’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,600	Closed	-$181K	–	610
2022 Q2	$181K	Buy	+2,600	New	+$196K	﹤0.01%	570
2021 Q3	–	Sell	-21,700	Closed	-$4.81M	–	567
2021 Q2	$4.81M	Buy	21,700 +3,500	+19%	+$681K	0.06%	399
2021 Q1	$2.41M	Buy	18,200 +2,000	+12%	+$316K	0.03%	485
2020 Q4	$2.8M	Buy	+16,200	New	+$2.22M	0.04%	443

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Första AP-fonden's NVCR Position: Q3 2022 in Review

Första AP-fonden sold out of NovoCure (NVCR) in Q3 2022, closing a stake of 2,600 shares — an estimated $181K sold.

Första AP-fonden first reported a position in NVCR in Q4 2020 and held it in 4 quarters. The position peaked at $4.81M in Q2 2021. 303 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

Första AP-fonden reported no remaining NovoCure position as of Q3 2022 after selling out during the quarter.
Första AP-fonden sold 2,600 NovoCure shares in Q3 2022, an estimated $181K.
Första AP-fonden first reported a position in NovoCure in Q4 2020 and held it in 4 quarters.
Första AP-fonden's NovoCure position peaked at $4.81M in Q2 2021.
303 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on Första AP-fonden's 13F filing for Q3 2022, filed 17 Oct 2022.